Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Profound Medical (PROF) Equity Average (2019 - 2026)

Profound Medical has reported Equity Average over the past 7 years, most recently at $49.3 million for Q4 2025.

  • For Q4 2025, Equity Average rose 8.16% year-over-year to $49.3 million; the TTM value through Dec 2025 reached $49.3 million, up 8.16%, while the annual FY2025 figure was $63.4 million, 38.42% up from the prior year.
  • Equity Average for Q4 2025 was $49.3 million at Profound Medical, up from $35.7 million in the prior quarter.
  • Over five years, Equity Average peaked at $37.3 billion in Q1 2022 and troughed at $34.8 million in Q3 2024.
  • A 5-year average of $6.9 billion and a median of $52.4 million in 2025 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: soared 80.51% in 2021 and later plummeted 99.84% in 2024.
  • Year by year, Equity Average stood at $84.3 million in 2021, then tumbled by 33.16% to $56.4 million in 2022, then crashed by 38.09% to $34.9 million in 2023, then soared by 30.6% to $45.6 million in 2024, then grew by 8.16% to $49.3 million in 2025.
  • Business Quant data shows Equity Average for PROF at $49.3 million in Q4 2025, $35.7 million in Q3 2025, and $45.0 million in Q2 2025.